Exos Asset Management’s Concord Acquisition Corp II Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 CNDA.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-4,566
Closed -$508 175
2024
Q1
$508 Buy
+4,566
New +$547 ﹤0.01% 176

Other funds holding CNDA.WS

Exos Asset Management's CNDA.WS Position: Q2 2024 in Review

Exos Asset Management sold out of Concord Acquisition Corp II Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 (CNDA.WS) in Q2 2024, closing a stake of 4,566 shares — an estimated $508 sold.

Exos Asset Management first reported a position in CNDA.WS in Q1 2024 and held it in 1 quarter. The position peaked at $508 in Q1 2024. 25 funds tracked by Wall St. Rank hold CNDA.WS as of Q2 2024.

  • Exos Asset Management reported no remaining Concord Acquisition Corp II Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 position as of Q2 2024 after selling out during the quarter.
  • Exos Asset Management sold 4,566 Concord Acquisition Corp II Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 shares in Q2 2024, an estimated $508.
  • Exos Asset Management first reported a position in Concord Acquisition Corp II Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 in Q1 2024 and held it in 1 quarter.
  • Exos Asset Management's Concord Acquisition Corp II Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 position peaked at $508 in Q1 2024.
  • 25 funds tracked by Wall St. Rank held Concord Acquisition Corp II Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 as of Q2 2024.

Based on Exos Asset Management's 13F filing for Q2 2024, filed 14 Aug 2024.